drugset / Trial / NCT04685694

Management of RPOC After Induced Abortion

NCT04685694

Phase 4 Completed 141 enrolled Tel-Aviv Sourasky Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

Randomized trial comparing expectant management and medical management in women diagnosed with retained products of conception after first trimester induced abortion

Timeline

Start
2020-01-01
Primary completion
2021-12-31
Completion
2022-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 800 ug Other

Indications

No indication recorded.